• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease

tetano

Editor, Senior Moderator
J Infect Chemother


. 2021 Oct 20;S1341-321X(21)00282-8.
doi: 10.1016/j.jiac.2021.10.013. Online ahead of print.
Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease


Ayako Okuhama[SUP] 1 [/SUP], Masatoshi Hotta[SUP] 2 [/SUP], Masahiro Ishikane[SUP] 3 [/SUP], Akira Kawashima[SUP] 1 [/SUP], Yusuke Miyazato[SUP] 1 [/SUP], Mari Terada[SUP] 4 [/SUP], Gen Yamada[SUP] 1 [/SUP], Kohei Kanda[SUP] 1 [/SUP], Makoto Inada[SUP] 1 [/SUP], Lubna Sato[SUP] 1 [/SUP], Mitsuhiro Sato[SUP] 1 [/SUP], Yutaro Akiyama[SUP] 1 [/SUP], Tetsuya Suzuki[SUP] 1 [/SUP], Takato Nakamoto[SUP] 1 [/SUP], Hidetoshi Nomoto[SUP] 1 [/SUP], Satoshi Ide[SUP] 1 [/SUP], Keiji Nakamura[SUP] 1 [/SUP], Sho Saito[SUP] 1 [/SUP], Noriko Kinoshita[SUP] 1 [/SUP], Kei Yamamoto[SUP] 1 [/SUP], Shinichiro Morioka[SUP] 1 [/SUP], Mugen Ujiie[SUP] 1 [/SUP], Kayoko Hayakawa[SUP] 1 [/SUP], Satoshi Kustuna[SUP] 1 [/SUP], Yoshitaka Shida[SUP] 2 [/SUP], Tsuyoshi Tajima[SUP] 2 [/SUP], Katsuji Teruya[SUP] 5 [/SUP], Yumi Funato[SUP] 6 [/SUP], Makiko Yamamoto[SUP] 6 [/SUP], Shinyu Izumi[SUP] 7 [/SUP], Masayuki Hojo[SUP] 7 [/SUP], Haruhito Sugiyama[SUP] 8 [/SUP], Norio Ohmagari[SUP] 1 [/SUP]



Affiliations

Abstract

Objectives: To alleviate the overflow of coronavirus disease 2019 (COVID-19) patients in hospitals, less invasive and simple criteria are required to triage the patients. We evaluated the relationship between COVID-19 severity and fatty liver on plain computed tomography (CT) scan performed on admission.
Methods: In this retrospective cohort study, we considered all COVID-19 patients at a large tertiary care hospital between January 31 and August 31, 2020. COVID-19 severity was categorized into severe (moderate and severe) and non-severe (asymptomatic and mild) groups, based on the Japanese National COVID-19 guidelines. Fatty liver was detected on plain CT scan. Multivariate logistic regression analysis was performed to evaluate factors associated with severe COVID-19.
Results: Of 222 patients (median age: 52 years), 3.2%, 58.1%, 20.7%, and 18.0% presented with asymptomatic, mild, moderate, and severe COVID-19, respectively. Although 59.9% had no fatty liver on plain CT, mild, moderate, and severe fatty liver occurred in 13.1%, 18.9%, and 8.1%, respectively. Age and presence of fatty liver were significantly associated with severe COVID-19.
Conclusion: Our study showed that fatty liver on plain CT scan on admission can become a risk factor for severe COVID-19. This finding may help clinicians to easily triage COVID-19 patients.

Keywords: COVID-19; Outcome; Pneumonia; Triage.
 
Back
Top Bottom